Description of the OXA-23 β-Lactamase Gene Located Within Tn2007 in a Clinical Isolate of Acinetobacter baumannii from Spain

Microbial Drug Resistance

Volumn 21, Issue 2, 2015, Pages 215-217

  Guerrero Lozano, Inmaculada ^a   Fernández Cuenca, Felipe ^b   Galán Sánchez, Fátima ^a   Egea, Pilar ^b   Rodríguez Iglesias, Manuel ^a   Pascual, Álvaro ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA-LACTAMASE OXA-23; CARBAPENEM DERIVATIVE; CARBAPENEMASE; TRANSPOSON;

ACINETOBACTER BAUMANNII; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA OXA 23 GENE; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; GENE INSERTION SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE; HUMAN; INTENSIVE CARE UNIT; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN; TRANSPOSON; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMIPENEM; MALE; MICROBIAL SENSITIVITY TESTS; SPAIN;

EID: 84925934890     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0155     Document Type: Article

References (15)

1. Adams-Haduch, J. M. , D. L. Paterson, H. E. Sidjabat, A. W. Pasculle, B. A. Potoski, and C. A. Muto. 2008. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob. Agents Chemother. 52:3837-3843.
2. Benjamin A. G. Evans, and S. G. Amyes. 2014. OXA blactamases. Clin. Microbiol. Rev. 27:241-263.
3. CLSI. 2012. Performance Standards for Antimicrobial Susceptibility Testing, M100-515. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Corvec, S. , L. Poirel, T. Naas, H. Drugeon, and P. Nordmann. 2007. Genetics and expression of the carbapenem-hydrolyzing oxacilinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 1530-1533.
5. Dallenne, C. , A. Da Costa, D. Decre, C. Favier, and G. Arlet. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490-495.
6. Doyle, D. , G. Peirano, C. Lascols, T. Lloyd, D. L. Church, and J. D. Pitout. 2012. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J. Clin. Microbiol. 50:3877-3880.
7. Espinal, P. , M. D. Macia, I. Roca, E. Gato, E. Ruiz, and F. Fernandez-Cuenca. 2013. First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. Antimicrob. Agents Chemother. 7:589-591.
8. Fernandez-Cuenca, F. , M. Tomas-Carmona, F. Caballero-Moyano, G. Bou, L. Martinez-Martinez, and J. Vila. 2013. In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp. : multicenter national study GEIH-REIPI-Ab 2010. Enferm Infecc. Microbiol. Clin. 31:4-9.
9. La Scola, B. , V. A. Gundi, A. Khamis, and D. Raoult. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44:827-832.
10. Merino, M. , M. Poza, I. Roca, M. J. Barba, M. D. Sousa, and J. Vila. 2013. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb. Drug Resist. 20:259-263.
11. Mosqueda, N. , P. Espinal, C. Cosgaya, S. Viota, V. Plasensia, and F. Alvarez-Lerma. 2013. Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of Acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob. Agents Chemother. 57:5155-5157.
12. Mugnier, P. D. , L. Poirel, T. Naas, and P. Nordmann. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect Dis. 16:35-40.
13. Poirel, L. , and P. Nordmann. 2006. Genetic structures at the origin of acquisition and expression of the carbapenemhydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:1442-1448.
14. Villalon, P. , S. Valdezate, M. J. Medina-Pascual, G. Carrasco, A. Vindel, and J. A. Saez-Nieto. 2013. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-betalactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J. Antimicrob. Chemother. 68:550-553.
15. Woodford, N. , M. J. Ellington, J. M. Coelho, J. F. Turton, M. E. Ward, and S. Brown. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.